{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["COVID-19", "PASC", "anti-inflammatory", "anti-oxidant", "medical therapy", "ozone therapy", "post-COVID", "review"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "36140358", "DateRevised": {"Year": "2022", "Month": "09", "Day": "28"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2022", "Month": "09", "Day": "12"}], "ELocationID": ["2258", "10.3390/biomedicines10092258"], "Journal": {"ISSN": "2227-9059", "JournalIssue": {"Volume": "10", "Issue": "9", "PubDate": {"Year": "2022", "Month": "Sep", "Day": "12"}}, "Title": "Biomedicines", "ISOAbbreviation": "Biomedicines"}, "ArticleTitle": "The Mito-Hormetic Mechanisms of Ozone in the Clearance of SARS-CoV2 and in the COVID-19 Therapy.", "Abstract": {"AbstractText": ["An increasing body of evidence in the literature is reporting the feasibility of using medical ozone as a possible alternative and adjuvant treatment for COVID-19 patients, significantly reducing hospitalization time, pro-inflammatory indicators, and coagulation markers and improving blood oxygenation parameters. In addition to the well-described ability of medical ozone in counteracting oxidative stress through the upregulation of the main anti-oxidant and scavenging enzymes, oxygen-ozone (O<sub>2</sub>-O<sub>3</sub>) therapy has also proved effective in reducing chronic inflammation and the occurrence of immune thrombosis, two key players involved in COVID-19 exacerbation and severity. As chronic inflammation and oxidative stress are also reported to be among the main drivers of the long sequelae of SARS-CoV2 infection, a rising number of studies is investigating the potential of O<sub>2</sub>-O<sub>3</sub> therapy to reduce and/or prevent the wide range of post-COVID (or PASC)-related disorders. This narrative review aims to describe the molecular mechanisms through which medical ozone acts, to summarize the clinical evidence on the use of O<sub>2</sub>-O<sub>3</sub> therapy as an alternative and adjuvant COVID-19 treatment, and to discuss the emerging potential of this approach in the context of PASC symptoms, thus offering new insights into effective and safe nonantiviral therapies for the fighting of this devastating pandemic."]}, "AuthorList": [{"Identifier": ["0000-0003-1789-8307"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37129 Verona, Italy."}], "LastName": "Chirumbolo", "ForeName": "Salvatore", "Initials": "S"}, {"Identifier": ["0000-0002-1246-2320"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology and Biotechnology, University of Pavia, 27100 Pavia, Italy."}, {"Identifier": [], "Affiliation": "Almo Collegio Borromeo, 27100 Pavia, Italy."}], "LastName": "Varesi", "ForeName": "Angelica", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Italian Scientific Society of Oxygen Ozone Therapy (SIOOT), 24100 Bergamo, Italy."}], "LastName": "Franzini", "ForeName": "Marianno", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Italian Scientific Society of Oxygen Ozone Therapy (SIOOT), 24100 Bergamo, Italy."}], "LastName": "Valdenassi", "ForeName": "Luigi", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Italian Scientific Society of Oxygen Ozone Therapy (SIOOT), 24100 Bergamo, Italy."}], "LastName": "Pandolfi", "ForeName": "Sergio", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Tirelli Clinical Group, 33170 Pordenone, Italy."}], "LastName": "Tirelli", "ForeName": "Umberto", "Initials": "U"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Unit of Nephrology and Dialysis, ICS Maugeri, University of Pavia, 27100 Pavia, Italy."}], "LastName": "Esposito", "ForeName": "Ciro", "Initials": "C"}, {"Identifier": ["0000-0003-3422-2747"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Drug Sciences, University of Pavia, 27100 Pavia, Italy."}], "LastName": "Ricevuti", "ForeName": "Giovanni", "Initials": "G"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Biomedicines", "NlmUniqueID": "101691304", "ISSNLinking": "2227-9059"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ivanov S.V., Panchenko V.Y. Infrared and microwave spectroscopy of ozone: Historical aspects. Phys. -Uspekhi. 1994;37:677\u2013695. doi: 10.1070/PU1994v037n07ABEH000034.", "ArticleIdList": ["10.1070/PU1994v037n07ABEH000034"]}, {"Citation": "Bocci V. Is it true that ozone is always toxic? The end of a dogma. Toxicol. Appl. Pharmacol. 2006;216:493\u2013504. doi: 10.1016/j.taap.2006.06.009.", "ArticleIdList": ["10.1016/j.taap.2006.06.009", "16890971"]}, {"Citation": "Bocci V., Borrelli E., Travagli V., Zanardi I. The ozone paradox: Ozone is a strong oxidant as well as a medical drug. Med. Res. Rev. 2009;29:646\u2013682. doi: 10.1002/med.20150.", "ArticleIdList": ["10.1002/med.20150", "19260079"]}, {"Citation": "Scassellati C., Galoforo A.C., Bonvicini C., Esposito C., Ricevuti G. Ozone: A natural bioactive molecule with antioxidant property as potential new strategy in aging and in neurodegenerative disorders. Ageing Res. Rev. 2020;63:101138. doi: 10.1016/j.arr.2020.101138.", "ArticleIdList": ["10.1016/j.arr.2020.101138", "PMC7428719", "32810649"]}, {"Citation": "Gali\u00e8 M., Covi V., Tabaracci G., Malatesta M. The Role of Nrf2 in the Antioxidant Cellular Response to Medical Ozone Exposure. Int. J. Mol. Sci. 2019;20:4009. doi: 10.3390/ijms20164009.", "ArticleIdList": ["10.3390/ijms20164009", "PMC6720777", "31426459"]}, {"Citation": "Viebahn-Haensler R., Fern\u00e1ndez O.L. Ozone in Medicine. The Low-Dose Ozone Concept and Its Basic Biochemical Mechanisms of Action in Chronic Inflammatory Diseases. Int. J. Mol. Sci. 2021;22:7890. doi: 10.3390/ijms22157890.", "ArticleIdList": ["10.3390/ijms22157890", "PMC8346137", "34360655"]}, {"Citation": "Ezraty B., Gennaris A., Barras F., Collet J.-F. Oxidative stress, protein damage and repair in bacteria. Nat. Rev. Microbiol. 2017;15:385\u2013396. doi: 10.1038/nrmicro.2017.26.", "ArticleIdList": ["10.1038/nrmicro.2017.26", "28420885"]}, {"Citation": "Juan C., de la Lastra J.P., Plou F., P\u00e9rez-Lebe\u00f1a E. The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies. Int. J. Mol. Sci. 2021;22:4642. doi: 10.3390/ijms22094642.", "ArticleIdList": ["10.3390/ijms22094642", "PMC8125527", "33924958"]}, {"Citation": "D\u2019Autr\u00e9aux B., Toledano M.B. ROS as signalling molecules: Mechanisms that generate specificity in ROS homeostasis. Nat. Rev. Mol. Cell Biol. 2007;8:813\u2013824. doi: 10.1038/nrm2256.", "ArticleIdList": ["10.1038/nrm2256", "17848967"]}, {"Citation": "Mittler R., Vanderauwera S., Suzuki N., Miller G., Tognetti V.B., Vandepoele K., Gollery M., Shulaev V., Van Breusegem F. ROS signaling: The new wave? Trends Plant Sci. 2011;16:300\u2013309. doi: 10.1016/j.tplants.2011.03.007.", "ArticleIdList": ["10.1016/j.tplants.2011.03.007", "21482172"]}, {"Citation": "Zhang J., Wang X., Vikash V., Ye Q., Wu D., Liu Y., Dong W. ROS and ROS-mediated cellular signaling. Oxid. Med. Cell. Longev. 2016;2016:4350965. doi: 10.1155/2016/4350965.", "ArticleIdList": ["10.1155/2016/4350965", "PMC4779832", "26998193"]}, {"Citation": "Phull A.-R., Nasir B., Haq I.U., Kim S.J. Oxidative stress, consequences and ROS mediated cellular signaling in rheumatoid arthritis. Chem. Interact. 2018;281:121\u2013136. doi: 10.1016/j.cbi.2017.12.024.", "ArticleIdList": ["10.1016/j.cbi.2017.12.024", "29258867"]}, {"Citation": "Rigotti G., Chirumbolo S. Biological Morphogenetic Surgery: A Minimally Invasive Procedure to Address Different Biological Mechanisms. Aesthetic Surg. J. 2018;39:745\u2013755. doi: 10.1093/asj/sjy198.", "ArticleIdList": ["10.1093/asj/sjy198", "30137183"]}, {"Citation": "Chirumbolo S., Bj\u00f8rklund G. PERM Hypothesis: The Fundamental Machinery Able to Elucidate the Role of Xenobiotics and Hormesis in Cell Survival and Homeostasis. Int. J. Mol. Sci. 2017;18:165. doi: 10.3390/ijms18010165.", "ArticleIdList": ["10.3390/ijms18010165", "PMC5297798", "28098843"]}, {"Citation": "Degechisa S.T., Dabi Y.T., Gizaw S.T. The mitochondrial associated endoplasmic reticulum membranes: A platform for the pathogenesis of inflammation-mediated metabolic diseases. Immun. Inflamm. Dis. 2022;10:e647. doi: 10.1002/iid3.647.", "ArticleIdList": ["10.1002/iid3.647", "PMC9168553", "35759226"]}, {"Citation": "Canella R., Martini M., Borriello R., Cavicchio C., Muresan X.M., Benedusi M., Cervellati F., Valacchi G. Modulation of Chloride Currents in Human Lung Epithelial Cells Exposed to Exogenous Oxidative Stress. J. Cell. Physiol. 2017;232:1817\u20131825. doi: 10.1002/jcp.25705.", "ArticleIdList": ["10.1002/jcp.25705", "27886375"]}, {"Citation": "Canella R., Benedusi M., Martini M., Cervellati F., Cavicchio C., Valacchi G. Role of Nrf2 in preventing oxidative stress induced chloride current alteration in human lung cells. J. Cell. Physiol. 2017;233:6018\u20136027. doi: 10.1002/jcp.26416.", "ArticleIdList": ["10.1002/jcp.26416", "29271475"]}, {"Citation": "Swanton T., Beswick J.A., Hammadi H., Morris L., Williams D., de Cesco S., El-Sharkawy L., Yu S., Green J., Davis J.B., et al. Selective inhibition of the K+ efflux sensitive NLRP3 pathway by Cl\u2212 channel modulation. Chem. Sci. 2020;11:11720\u201311728. doi: 10.1039/D0SC03828H.", "ArticleIdList": ["10.1039/D0SC03828H", "PMC8162947", "34094411"]}, {"Citation": "Kaivola J., Nyman T.A., Matikainen S. Inflammasomes and SARS-CoV-2 Infection. Viruses. 2021;13:2513. doi: 10.3390/v13122513.", "ArticleIdList": ["10.3390/v13122513", "PMC8706865", "34960782"]}, {"Citation": "Shang C., Liu Z., Zhu Y., Lu J., Ge C., Zhang C., Li N., Jin N., Li Y., Tian M., et al. SARS-CoV-2 Causes Mitochondrial Dysfunction and Mitophagy Impairment. Front. Microbiol. 2022;12:780768. doi: 10.3389/fmicb.2021.780768.", "ArticleIdList": ["10.3389/fmicb.2021.780768", "PMC8770829", "35069483"]}, {"Citation": "Hennig P., Garstkiewicz M., Grossi S., Di Filippo M., French L.E., Beer H.-D. The Crosstalk between Nrf2 and Inflammasomes. Int. J. Mol. Sci. 2018;19:562. doi: 10.3390/ijms19020562.", "ArticleIdList": ["10.3390/ijms19020562", "PMC5855784", "29438305"]}, {"Citation": "Chirumbolo S., Bj\u00f8rklund G. The bimodal SARS-CoV-2 outbreak in Italy as an effect of environmental and allergic causes. J. Allergy Clin. Immunol. 2020;146:331\u2013332. doi: 10.1016/j.jaci.2020.05.011.", "ArticleIdList": ["10.1016/j.jaci.2020.05.011", "PMC7253996", "32507495"]}, {"Citation": "Kettle A.J., Winterbourn C.C. Do neutrophils produce ozone? An appraisal of current evidence. BioFactors. 2005;24:41\u201345. doi: 10.1002/biof.5520240105.", "ArticleIdList": ["10.1002/biof.5520240105", "16403962"]}, {"Citation": "Babior B.M., Takeuchi C., Ruedi J., Gutierrez A., Wentworth P. Investigating antibody-catalyzed ozone generation by human neutrophils. Proc. Natl. Acad. Sci. USA. 2003;100:3031\u20133034. doi: 10.1073/pnas.0530251100.", "ArticleIdList": ["10.1073/pnas.0530251100", "PMC152239", "12601145"]}, {"Citation": "B\u00e1rcena C., Mayoral P., Quir\u00f3s P.M. Mitohormesis, an Antiaging Paradigm. Int. Rev. Cell Mol. Biol. 2018;340:35\u201377. doi: 10.1016/bs.ircmb.2018.05.002.", "ArticleIdList": ["10.1016/bs.ircmb.2018.05.002", "30072093"]}, {"Citation": "Ristow M., Schmeisser K. Mitohormesis: Promoting Health and Lifespan by Increased Levels of Reactive Oxygen Species (ROS) Dose-Response. 2014;12:288\u2013341. doi: 10.2203/dose-response.13-035.Ristow.", "ArticleIdList": ["10.2203/dose-response.13-035.Ristow", "PMC4036400", "24910588"]}, {"Citation": "Olagnier D., Farahani E., Thyrsted J., Blay-Cadanet J., Herengt A., Idorn M., Hait A., Hernaez B., Knudsen A., Iversen M.B., et al. Author Correction: SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate. Nat. Commun. 2020;11:5419. doi: 10.1038/s41467-020-19363-y.", "ArticleIdList": ["10.1038/s41467-020-19363-y", "PMC7578803", "33087717"]}, {"Citation": "Ma Q. Role of Nrf2 in Oxidative Stress and Toxicity. Annu. Rev. Pharmacol. Toxicol. 2013;53:401\u2013426. doi: 10.1146/annurev-pharmtox-011112-140320.", "ArticleIdList": ["10.1146/annurev-pharmtox-011112-140320", "PMC4680839", "23294312"]}, {"Citation": "Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., Oyake T., Hayashi N., Satoh K., Hatayama I., et al. An Nrf2/Small Maf Heterodimer Mediates the Induction of Phase II Detoxifying Enzyme Genes through Antioxidant Response Elements. Biochem. Biophys. Res. Commun. 1997;236:313\u2013322. doi: 10.1006/bbrc.1997.6943.", "ArticleIdList": ["10.1006/bbrc.1997.6943", "9240432"]}, {"Citation": "Venugopal R., Jaiswal A.K. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase 1 gene. Proc. Natl. Acad. Sci. USA. 1996;93:14960\u201314965. doi: 10.1073/pnas.93.25.14960.", "ArticleIdList": ["10.1073/pnas.93.25.14960", "PMC26245", "8962164"]}, {"Citation": "Larini A., Bianchi L., Bocci V. Effect of 4-hydroxynonenal on antioxidant capacity and apoptosis induction in Jurkat T cells. Free Radic. Res. 2004;38:509\u2013516. doi: 10.1080/10715760410001684649.", "ArticleIdList": ["10.1080/10715760410001684649", "15293559"]}, {"Citation": "Singhal S.S., Singh S.P., Singhal P., Horne D., Singhal J., Awasthi S. Antioxidant role of glutathione S-transferases: 4-Hydroxynonenal, a key molecule in stress-mediated signaling. Toxicol. Appl. Pharmacol. 2015;289:361\u2013370. doi: 10.1016/j.taap.2015.10.006.", "ArticleIdList": ["10.1016/j.taap.2015.10.006", "PMC4852854", "26476300"]}, {"Citation": "Nguyen T., Sherratt P.J., Pickett C.B. Regulatory Mechanisms Controlling Gene Expression Mediated by the Antioxidant Response Element. Annu. Rev. Pharmacol. Toxicol. 2003;43:233\u2013260. doi: 10.1146/annurev.pharmtox.43.100901.140229.", "ArticleIdList": ["10.1146/annurev.pharmtox.43.100901.140229", "12359864"]}, {"Citation": "Ma Q. Xenobiotic-Activated Receptors: From Transcription to Drug Metabolism to Disease. Chem. Res. Toxicol. 2008;21:1651\u20131671. doi: 10.1021/tx800156s.", "ArticleIdList": ["10.1021/tx800156s", "18707139"]}, {"Citation": "Chirumbolo S., Valdenassi L., Simonetti V., Bertossi D., Ricevuti G., Franzini M., Pandolfi S. Insights on the mechanisms of action of ozone in the medical therapy against COVID-19. Int. Immunopharmacol. 2021;96:107777. doi: 10.1016/j.intimp.2021.107777.", "ArticleIdList": ["10.1016/j.intimp.2021.107777", "PMC8112288", "34020394"]}, {"Citation": "Kovac S., Angelova P.R., Holmstr\u00f6m K.M., Zhang Y., Dinkova-Kostova A.T., Abramov A.Y. Nrf2 regulates ROS production by mitochondria and NADPH oxidase. Biochim. Biophys. Acta. 2015;1850:794\u2013801. doi: 10.1016/j.bbagen.2014.11.021.", "ArticleIdList": ["10.1016/j.bbagen.2014.11.021", "PMC4471129", "25484314"]}, {"Citation": "Kasai S., Shimizu S., Tatara Y., Mimura J., Itoh K. Regulation of Nrf2 by Mitochondrial Reactive Oxygen Species in Physiology and Pathology. Biomolecules. 2020;10:320. doi: 10.3390/biom10020320.", "ArticleIdList": ["10.3390/biom10020320", "PMC7072240", "32079324"]}, {"Citation": "Ryan D.G., Knatko E.V., Casey A.M., Hukelmann J.L., Naidu S.D., Brenes A.J., Ekkunagul T., Baker C., Higgins M., Tronci L., et al. Nrf2 activation reprograms macrophage intermediary metabolism and suppresses the type I interferon response. iScience. 2022;25:103827. doi: 10.1016/j.isci.2022.103827.", "ArticleIdList": ["10.1016/j.isci.2022.103827", "PMC8844662", "35198887"]}, {"Citation": "Cattel F., Giordano S., Bertiond C., Lupia T., Corcione S., Scaldaferri M., Angelone L., De Rosa F.G. Ozone therapy in COVID-19: A narrative review. Virus Res. 2020;291:198207. doi: 10.1016/j.virusres.2020.198207.", "ArticleIdList": ["10.1016/j.virusres.2020.198207", "PMC7585733", "33115670"]}, {"Citation": "Izadi M., Cegolon L., Javanbakht M., Sarafzadeh A., Abolghasemi H., Alishiri G., Zhao S., Einollahi B., Kashaki M., Jonaidi-Jafari N., et al. Ozone therapy for the treatment of COVID-19 pneumonia: A scoping review. Int. Immunopharmacol. 2020;92:107307. doi: 10.1016/j.intimp.2020.107307.", "ArticleIdList": ["10.1016/j.intimp.2020.107307", "PMC7752030", "33476982"]}, {"Citation": "Villani E., Ranaldi G., Franza L. Rationale for ozone-therapy as an adjuvant therapy in COVID-19: A narrative review. Med. Gas. Res. 2020;10:134\u2013138. doi: 10.4103/2045-9912.289462.", "ArticleIdList": ["10.4103/2045-9912.289462", "PMC8086623", "33004712"]}, {"Citation": "Shah M., Captain J., Vaidya V., Kulkarni A., Valsangkar K., Nair P.M., Ganu G. Safety and efficacy of ozone therapy in mild to moderate COVID-19 patients: A phase 1/11 randomized control trial (SEOT study) Int. Immunopharmacol. 2020;91:107301. doi: 10.1016/j.intimp.2020.107301.", "ArticleIdList": ["10.1016/j.intimp.2020.107301", "PMC7758022", "33421928"]}, {"Citation": "Hern\u00e1ndez A., Vi\u00f1als M., Pablos A., Vil\u00e1s F., Papadakos P.J., Wijeysundera D.N., Bergese S.D., Vives M. Ozone therapy for patients with COVID-19 pneumonia: Preliminary report of a prospective case-control study. Int. Immunopharmacol. 2020;90:107261. doi: 10.1016/j.intimp.2020.107261.", "ArticleIdList": ["10.1016/j.intimp.2020.107261", "PMC7833586", "33310665"]}, {"Citation": "\u00c7olak \u015e., Yavuz B.G., Yavuz M., \u00d6z\u00e7elik B., \u00d6ner M., \u00d6zg\u00fcltekin A., \u015eenbayrak S. Effectiveness of ozone therapy in addition to conventional treatment on mortality in patients with COVID-19. Int. J. Clin. Pract. 2021;75:e14321. doi: 10.1111/ijcp.14321.", "ArticleIdList": ["10.1111/ijcp.14321", "PMC8236993", "33971067"]}, {"Citation": "Franzini M., Valdenassi L., Ricevuti G., Chirumbolo S., Depfenhart M., Bertossi D., Tirelli U. Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported. Int. Immunopharmacol. 2020;88:106879. doi: 10.1016/j.intimp.2020.106879.", "ArticleIdList": ["10.1016/j.intimp.2020.106879", "PMC7414302", "32795898"]}, {"Citation": "Cenci A., Macchia I., La Sorsa V., Sbarigia C., Di Donna V., Pietraforte D. Mechanisms of Action of Ozone Therapy in Emerging Viral Diseases: Immunomodulatory Effects and Therapeutic Advantages with Reference to SARS-CoV-2. Front. Microbiol. 2022;13:871645. doi: 10.3389/fmicb.2022.871645.", "ArticleIdList": ["10.3389/fmicb.2022.871645", "PMC9069003", "35531273"]}, {"Citation": "Hern\u00e1ndez A., Vi\u00f1als M., Isidoro T., Vil\u00e1s F. Potential Role of Oxygen\u2013Ozone Therapy in Treatment of COVID-19 Pneumonia. Am. J. Case Rep. 2020;21:e925849-1\u2013e925849-6. doi: 10.12659/AJCR.925849.", "ArticleIdList": ["10.12659/AJCR.925849", "PMC7476746", "32804917"]}, {"Citation": "Zheng Z., Dong M., Hu K. A preliminary evaluation on the efficacy of ozone therapy in the treatment of COVID-19. J. Med. Virol. 2020;92:2348\u20132350. doi: 10.1002/jmv.26040.", "ArticleIdList": ["10.1002/jmv.26040", "PMC7280732", "32437014"]}, {"Citation": "Araimo F., Imperiale C., Tordiglione P., Ceccarelli G., Borrazzo C., Alessandri F., Santinelli L., Innocenti G.P., Pinacchio C., Mauro V., et al. Ozone as adjuvant support in the treatment of COVID-19: A preliminary report of probiozovid trial. J. Med. Virol. 2020;93:2210\u20132220. doi: 10.1002/jmv.26636.", "ArticleIdList": ["10.1002/jmv.26636", "33111980"]}, {"Citation": "Fern\u00e1ndez-Cuadros M.E., Albaladejo-Flor\u00edn M.J., \u00c1lava-Rabasa S., Gallego-Galiana J., P\u00e9rez-Cruz G.F., Usandizaga-Elio I., Pacios E., Torres-Garc\u00eda D.E., Pe\u00f1a-Lora D., Casique-Bocanegra L., et al. Compassionate Use of Rectal Ozone (O3) in Severe COVID-19 Pneumonia: A Case-Control Study. SN Compr. Clin. Med. 2021;3:1185\u20131199. doi: 10.1007/s42399-021-00849-9.", "ArticleIdList": ["10.1007/s42399-021-00849-9", "PMC7984736", "33778374"]}, {"Citation": "Hendawy H.A., Mosallam W., Abuelnaga M.E., Sabry A.M. Old Treatment for a New Disease: Can Rectal Ozone Insufflation Be Used for COVID-19 Management? A Case Report. SN Compr. Clin. Med. 2021;3:1424\u20131427. doi: 10.1007/s42399-021-00895-3.", "ArticleIdList": ["10.1007/s42399-021-00895-3", "PMC8046266", "33875977"]}, {"Citation": "Sharma A., Shah M., Sane H., Gokulchandran N., Paranjape A., Khubchandani P., Captain J., Shirke S., Kul-karni P. Intravenous ozonized saline therapy as prophylaxis for healthcare workers (HCWs) in a dedicated COVID-19 hospital in India \u2013A retrospective study. Eur. Rev. Med. Pharm. Sci. 2021;25:3632\u20133639. doi: 10.26355/EURREV_202105_25847.", "ArticleIdList": ["10.26355/EURREV_202105_25847", "34002840"]}, {"Citation": "Sozio E., De Monte A., Sermann G., Bassi F., Sacchet D., Sbrana F., Ripoli A., Curcio F., Fabris M., Marengo S., et al. CORonavirus-19 mild to moderate pneumonia Management with blood Ozonization in patients with Respiratory failure (CORMOR) multicentric prospective randomized clinical trial. Int. Immunopharmacol. 2021;98:107874. doi: 10.1016/j.intimp.2021.107874.", "ArticleIdList": ["10.1016/j.intimp.2021.107874", "PMC8196321", "34186281"]}, {"Citation": "Sharma A., Shah M., Lakshmi S., Sane H., Captain J., Gokulchandran N., Khubchandani P., Pradeep M., Gote P., Tuppekar B., et al. A pilot study for treatment of COVID-19 patients in moderate stage using intravenous administration of ozonized saline as an adjuvant treatment-registered clinical trial. Int. Immunopharmacol. 2021;96:107743. doi: 10.1016/j.intimp.2021.107743.", "ArticleIdList": ["10.1016/j.intimp.2021.107743", "PMC8084612", "33984718"]}, {"Citation": "Tascini C., Sermann G., Pagotto A., Sozio E., De Carlo C., Giacinta A., Sbrana F., Ripoli A., Castaldo N., Merelli M., et al. Blood ozonization in patients with mild to moderate COVID-19 pneumonia: A single centre experience. Intern. Emerg. Med. 2020;16:669\u2013675. doi: 10.1007/s11739-020-02542-6.", "ArticleIdList": ["10.1007/s11739-020-02542-6", "PMC7603641", "33131033"]}, {"Citation": "Dengiz E., \u00d6zcan \u00c7., G\u00fcven Y.\u0130., U\u00e7ar S., Ener B.K., S\u00f6zen S., Ya\u011fc\u0131 B., G\u00fczel \u0130.A., Yi\u011fit B., Anda\u00e7 A., et al. Ozone Gas Applied through Nebulization as Adjuvant Treatment for Lung Respiratory Diseases Due to COVID-19 Infections: A Prospective Randomized Trial. Med. Gas. Res. 2022;12:55\u201359. doi: 10.4103/2045-9912.326001.", "ArticleIdList": ["10.4103/2045-9912.326001", "PMC8562398", "34677153"]}, {"Citation": "Tirelli U., Franzini M., Valdenassi L., Pisconti S., Taibi R., Torrisi C., Pandolfi S., Chirumbolo S. Fatigue in Post-Acute Sequelae of SARS-CoV2 (PASC) Treated with Oxygen-Ozone Autohemotherapy-Preliminary Results on 100 Patients. Eur. Rev. Med. Pharm. Sci. 2021;25:5871\u20135875. doi: 10.26355/eurrev_202109_26809.", "ArticleIdList": ["10.26355/eurrev_202109_26809", "34604980"]}, {"Citation": "Liu Q., Zhang D., Hu D., Zhou X., Zhou Y. The role of mitochondria in NLRP3 inflammasome activation. Mol. Immunol. 2018;103:115\u2013124. doi: 10.1016/j.molimm.2018.09.010.", "ArticleIdList": ["10.1016/j.molimm.2018.09.010", "30248487"]}, {"Citation": "Patergnani S., Bouhamida E., Leo S., Pinton P., Rimessi A. Mitochondrial Oxidative Stress and \u201cMito-Inflammation\u201d: Actors in the Diseases. Biomedicines. 2021;9:216. doi: 10.3390/biomedicines9020216.", "ArticleIdList": ["10.3390/biomedicines9020216", "PMC7923430", "33672477"]}, {"Citation": "Chen Y., Zhou Z., Min W. Mitochondria, Oxidative Stress and Innate Immunity. Front. Physiol. 2018;9:1487. doi: 10.3389/fphys.2018.01487.", "ArticleIdList": ["10.3389/fphys.2018.01487", "PMC6200916", "30405440"]}, {"Citation": "Bonaventura A., Vecchi\u00e9 A., Dagna L., Martinod K., Dixon D.L., Van Tassell B.W., Dentali F., Montecucco F., Massberg S., Levi M., et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat. Rev. Immunol. 2021;21:319\u2013329. doi: 10.1038/s41577-021-00536-9.", "ArticleIdList": ["10.1038/s41577-021-00536-9", "PMC8023349", "33824483"]}, {"Citation": "Infantes E.C., Bautista J.T., Beltr\u00e1n-Povea A., Cahuana G.M., Soria B., Nabil H., Bedoya F., Tejedo J.R. Regulation of mitochondrial function and endoplasmic reticulum stress by nitric oxide in pluripotent stem cells. World J. Stem Cells. 2017;9:26\u201336. doi: 10.4252/wjsc.v9.i2.26.", "ArticleIdList": ["10.4252/wjsc.v9.i2.26", "PMC5329687", "28289506"]}, {"Citation": "Nisoli E., Falcone S., Tonello C., Cozzi V., Palomba L., Fiorani M., Pisconti A., Brunelli S., Cardile A., Francolini M., et al. Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. Proc. Natl. Acad. Sci. USA. 2004;101:16507\u201316512. doi: 10.1073/pnas.0405432101.", "ArticleIdList": ["10.1073/pnas.0405432101", "PMC534517", "15545607"]}, {"Citation": "Valerio A., Nisoli E. Nitric oxide, interorganelle communication, and energy flow: A novel route to slow aging. Front. Cell Dev. Biol. 2015;3:6. doi: 10.3389/fcell.2015.00006.", "ArticleIdList": ["10.3389/fcell.2015.00006", "PMC4319459", "25705617"]}, {"Citation": "\u00c5kerstr\u00f6m S., Mousavi-Jazi M., Klingstr\u00f6m J., Leijon M., Lundkvist A., Mirazimi A. Nitric Oxide Inhibits the Replication Cycle of Severe Acute Respiratory Syndrome Coronavirus. J. Virol. 2005;79:1966\u20131969. doi: 10.1128/JVI.79.3.1966-1969.2005.", "ArticleIdList": ["10.1128/JVI.79.3.1966-1969.2005", "PMC544093", "15650225"]}, {"Citation": "Mart\u00ednez M.C., Morell F.B., Raya A., Rom\u00e1 J., Aldasoro M., Vila J., Lluch S., Romero F.J. 4-Hydroxynonenal, a Lipid Peroxidation Product, Induces Relaxation of Human Cerebral Arteries. J. Cereb. Blood Flow Metab. 1994;14:693\u2013696. doi: 10.1038/jcbfm.1994.87.", "ArticleIdList": ["10.1038/jcbfm.1994.87", "8014218"]}, {"Citation": "Romero F.J., Romero M.J., Morell F.B., Mart\u00ednez M., Medina P., Lluch S. 4-Hydroxynonenal-Induced Relaxation of Human Mesenteric Arteries. Free Radic. Biol. Med. 1997;23:521\u2013523. doi: 10.1016/S0891-5849(97)00119-6.", "ArticleIdList": ["10.1016/S0891-5849(97)00119-6", "9214591"]}, {"Citation": "Maulucci G., Daniel B., Cohen O., Avrahami Y., Sasson S. Hormetic and regulatory effects of lipid peroxidation mediators in pancreatic beta cells. Mol. Asp. Med. 2016;49:49\u201377. doi: 10.1016/j.mam.2016.03.001.", "ArticleIdList": ["10.1016/j.mam.2016.03.001", "27012748"]}, {"Citation": "Chapple S.J., Cheng X., Mann G.E. Effects of 4-hydroxynonenal on vascular endothelial and smooth muscle cell redox signaling and function in health and disease. Redox Biol. 2013;1:319\u2013331. doi: 10.1016/j.redox.2013.04.001.", "ArticleIdList": ["10.1016/j.redox.2013.04.001", "PMC3757694", "24024167"]}, {"Citation": "Harry R.S., Hiatt L.A., Kimmel D.W., Carney C.K., Halfpenny K.C., Cliffel D.E., Wright D.W. Metabolic Impact of 4-Hydroxynonenal on Macrophage-Like RAW 264.7 Function and Activation. Chem. Res. Toxicol. 2012;25:1643\u20131651. doi: 10.1021/tx3001048.", "ArticleIdList": ["10.1021/tx3001048", "PMC3444243", "22799741"]}, {"Citation": "Bocci V.A., Zanardi I., Travagli V. Ozone acting on human blood yields a hormetic dose-response relationship. J. Transl. Med. 2011;9:66. doi: 10.1186/1479-5876-9-66.", "ArticleIdList": ["10.1186/1479-5876-9-66", "PMC3125221", "21575276"]}, {"Citation": "Shinriki N., Suzuki T., Takama K., Fukunaga K., Ohgiya S., Kubota K., Miura T. Susceptibilities of Plasma Antioxi-dants and Erythrocyte Constituents to Low Levels of Ozone. Haematologia (Budap) 1998;29:229\u2013239.", "ArticleIdList": ["10069448"]}, {"Citation": "Gatbonton-Schwager T.N., Sadhukhan S., Zhang G.-F., Letterio J.J., Tochtrop G.P. Identification of a negative feedback loop in biological oxidant formation fegulated by 4-hydroxy-2-(E)-nonenal. Redox Biol. 2014;2:755\u2013763. doi: 10.1016/j.redox.2014.04.009.", "ArticleIdList": ["10.1016/j.redox.2014.04.009", "PMC4085345", "25009777"]}, {"Citation": "Bocci V., Aldinucci C., Mosci F., Carraro F., Valacchi G. Ozonation of Human Blood Induces a Remarkable Upregulation of Heme Oxygenase-1 and Heat Stress Protein-70. Mediat. Inflamm. 2007;2007:26785. doi: 10.1155/2007/26785.", "ArticleIdList": ["10.1155/2007/26785", "PMC2233812", "18274635"]}, {"Citation": "Hull T.D., Boddu R., Guo L., Tisher C.C., Traylor A.M., Patel B., Joseph R., Prabhu S.D., Suliman H.B., Piantadosi C.A., et al. Heme oxygenase-1 regulates mitochondrial quality control in the heart. JCI Insight. 2016;1:e85817. doi: 10.1172/jci.insight.85817.", "ArticleIdList": ["10.1172/jci.insight.85817", "PMC4838906", "27110594"]}, {"Citation": "Korski K.I., Kubli D.A., Wang B.J., Khalafalla F.G., Monsanto M.M., Firouzi F., Echeagaray O.H., Kim T., Adamson R.M., Dembitsky W.P., et al. Hypoxia Prevents Mitochondrial Dysfunction and Senescence in Human c-Kit+ Cardiac Progenitor Cells. Stem. Cells. 2019;37:555\u2013567. doi: 10.1002/stem.2970.", "ArticleIdList": ["10.1002/stem.2970", "PMC6588544", "30629785"]}, {"Citation": "Grieb P., Swiatkiewicz M., Prus K., Rejdak K. Hypoxia may be a determinative factor in COVID-19 progression. Curr. Res. Pharmacol. Drug Discov. 2021;2:100030. doi: 10.1016/j.crphar.2021.100030.", "ArticleIdList": ["10.1016/j.crphar.2021.100030", "PMC8106824", "34870146"]}, {"Citation": "Bansal S., Biswas G., Avadhani N.G. Mitochondria-targeted heme oxygenase-1 induces oxidative stress and mitochondrial dysfunction in macrophages, kidney fibroblasts and in chronic alcohol hepatotoxicity. Redox Biol. 2013;2:273\u2013283. doi: 10.1016/j.redox.2013.07.004.", "ArticleIdList": ["10.1016/j.redox.2013.07.004", "PMC3909819", "24494190"]}, {"Citation": "Shen H.-H., Wang C.-J., Zhang X.-Y., Sheng Y.-R., Yang S.-L., Zheng Z.-M., Shi J.-L., Qiu X.-M., Xie F., Li M.-Q. HIF1A-induced heme oxygenase 1 promotes the survival of decidual stromal cells against excess heme-mediated oxidative stress. Reproduction. 2022;163:33\u201343. doi: 10.1530/REP-21-0314.", "ArticleIdList": ["10.1530/REP-21-0314", "34874275"]}, {"Citation": "Agani F.H., Puchowicz M., Chavez J.C., Pichiule P., LaManna J. Role of nitric oxide in the regulation of HIF-1\u03b1 expression during hypoxia. Am. J. Physiol. Physiol. 2002;283:C178\u2013C186. doi: 10.1152/ajpcell.00381.2001.", "ArticleIdList": ["10.1152/ajpcell.00381.2001", "12055086"]}, {"Citation": "Deng L., Meng W., Li D., Qiu D., Wang S., Liu H. The Effect of Ozone on Hypoxia, Hemolysis and Morphological Change of Blood from Patients with Aortic Dissection (AD): A Preliminary in Vitro Experiment of Ozonated Autohemo-therapy for Treating AD. Am. J. Transl. Res. 2018;10:1829\u20131840.", "ArticleIdList": ["PMC6038082", "30018723"]}, {"Citation": "Tian M., Liu W., Li X., Zhao P., Shereen M.A., Zhu C., Huang S., Liu S., Yu X., Yue M., et al. HIF-1\u03b1 promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19. Signal Transduct. Target. Ther. 2021;6:308. doi: 10.1038/s41392-021-00726-w.", "ArticleIdList": ["10.1038/s41392-021-00726-w", "PMC8371950", "34408131"]}, {"Citation": "Dunn L.L., Kong S.M., Tumanov S., Chen W., Cantley J., Ayer A., Maghzal G.J., Midwinter R.G., Chan K.H., Ng M.K., et al. Hmox1 (Heme Oxygenase-1) Protects Against Ischemia-Mediated Injury via Stabilization of HIF-1\u03b1 (Hypoxia-Inducible Factor-1\u03b1) Arter. Thromb. Vasc. Biol. 2020;41:317\u2013330. doi: 10.1161/ATVBAHA.120.315393.", "ArticleIdList": ["10.1161/ATVBAHA.120.315393", "33207934"]}, {"Citation": "Papandreou I., Cairns R.A., Fontana L., Lim A.L., Denko N.C. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 2006;3:187\u2013197. doi: 10.1016/j.cmet.2006.01.012.", "ArticleIdList": ["10.1016/j.cmet.2006.01.012", "16517406"]}, {"Citation": "Pag\u00e9 E.L., Chan D.A., Giaccia A.J., Levine M., Richard D.E. Hypoxia-inducible Factor-1\u03b1 Stabilization in Nonhypoxic Conditions: Role of Oxidation and Intracellular Ascorbate Depletion. Mol. Biol. Cell. 2008;19:86\u201394. doi: 10.1091/mbc.e07-06-0612.", "ArticleIdList": ["10.1091/mbc.e07-06-0612", "PMC2174200", "17942596"]}, {"Citation": "Jay R.R., Howard R. A Plausible \u201cPenny\u201d Costing Effective Treatment for Corona Virus-Ozone Therapy. J. Infect. Dis. Epidemiol. 2020;6:113. doi: 10.23937/2474-3658/1510113.", "ArticleIdList": ["10.23937/2474-3658/1510113"]}, {"Citation": "Fern\u00e1ndez-Cuadros M.E., Albaladejo-Flor\u00edn M.J., Pe\u00f1a-Lora D., \u00c1lava-Rabasa S., P\u00e9rez-Moro O.S. Ozone (O3) and SARS-CoV-2: Physiological Bases and Their Therapeutic Possibilities According to COVID-19 Evolutionary Stage. SN Compr. Clin. Med. 2020;2:1094\u20131102. doi: 10.1007/s42399-020-00328-7.", "ArticleIdList": ["10.1007/s42399-020-00328-7", "PMC7340747", "32838159"]}, {"Citation": "Manjunath S.N., Sakar M., Katapadi M., Balakrishna R.G. Recent case studies on the use of ozone to combat coronavirus: Problems and perspectives. Environ. Technol. Innov. 2020;21:101313. doi: 10.1016/j.eti.2020.101313.", "ArticleIdList": ["10.1016/j.eti.2020.101313", "PMC7733684", "33344687"]}, {"Citation": "Yilmaz N., Eren E., Oz C. COVID-19 and Ozone. Cyprus. J. Med. Sci. 2021;5:365\u2013372. doi: 10.5152/cjms.2020.2658.", "ArticleIdList": ["10.5152/cjms.2020.2658"]}, {"Citation": "Yousefi B., Banihashemian S.Z., Feyzabadi Z.K., Hasanpour S., Kokhaei P., Abdolshahi A., Emadi A., Eslami M. Potential Therapeutic Effect of Oxygen-Ozone in Controlling of COVID-19 Disease. Med. Gas. Res. 2022;12:33\u201340. doi: 10.4103/2045-9912.325989.", "ArticleIdList": ["10.4103/2045-9912.325989", "PMC8562402", "34677149"]}, {"Citation": "Gu Y.Q. Suggestion for a Long-Term Effective Disinfection to Eliminate the COVID-19 Epidemic. BAOJ Microbiol. 2022;6:1004."}, {"Citation": "Bocci V., Valacchi G. Nrf2 activation as target to implement therapeutic treatments. Front. Chem. 2015;3:4. doi: 10.3389/fchem.2015.00004.", "ArticleIdList": ["10.3389/fchem.2015.00004", "PMC4313773", "25699252"]}, {"Citation": "Falero-Perez J., Song Y.-S., Sorenson C.M., Sheibani N. CYP1B1: A key regulator of redox homeostasis. Trends Cell Mol. Biol. 2018;13:27\u201345.", "ArticleIdList": ["PMC6422340", "30894785"]}, {"Citation": "Wang G., Xiao B., Deng J., Gong L., Li Y., Li J., Zhong Y. The Role of Cytochrome P450 Enzymes in COVID-19 Pathogenesis and Therapy. Front. Pharmacol. 2022;13:791922. doi: 10.3389/fphar.2022.791922.", "ArticleIdList": ["10.3389/fphar.2022.791922", "PMC8847594", "35185562"]}, {"Citation": "Afaq F., Abu Zaid M., Pelle E., Khan N., Syed D.N., Matsui M.S., Maes D., Mukhtar H. Aryl Hydrocarbon Receptor Is an Ozone Sensor in Human Skin. J. Investig. Dermatol. 2009;129:2396\u20132403. doi: 10.1038/jid.2009.85.", "ArticleIdList": ["10.1038/jid.2009.85", "19536146"]}, {"Citation": "Jacob A., Hartz A.M., Potin S., Coumoul X., Yousif S., Scherrmann J.-M., Bauer B., Decl\u00e8ves X. Aryl hydrocarbon receptor-dependent upregulation of Cyp1b1 by TCDD and diesel exhaust particles in rat brain microvessels. Fluids Barriers CNS. 2011;8:23. doi: 10.1186/2045-8118-8-23.", "ArticleIdList": ["10.1186/2045-8118-8-23", "PMC3180256", "21867498"]}, {"Citation": "Chirumbolo S. The Role of Quercetin, Flavonols and Flavones in Modulating Inflammatory Cell Function. Inflamm. Allergy-Drug Targets. 2010;9:263\u2013285. doi: 10.2174/187152810793358741.", "ArticleIdList": ["10.2174/187152810793358741", "20887269"]}, {"Citation": "Kvarantan A., Balta V., Zarkovic N., Horvat T., Vukovic T., Zarkovic K., Kalogjera L. Association between aryl hydrocarbon receptor and 4-hydroxynonenal in oxidative stress-mediated chronic rhinosinusitis with nasal polyps. Eur. J. Inflamm. 2021;19 doi: 10.1177/20587392211065613.", "ArticleIdList": ["10.1177/20587392211065613"]}, {"Citation": "Larigot L., Benoit L., Koual M., Tomkiewicz C., Barouki R., Coumoul X. Aryl Hydrocarbon Receptor and Its Diverse Ligands and Functions: An Exposome Receptor. Annu. Rev. Pharmacol. Toxicol. 2022;62:383\u2013404. doi: 10.1146/annurev-pharmtox-052220-115707.", "ArticleIdList": ["10.1146/annurev-pharmtox-052220-115707", "34499523"]}, {"Citation": "Hwang H.J., Dornbos P., Steidemann M., Dunivin T.K., Rizzo M., LaPres J.J. Mitochondrial-targeted aryl hydrocarbon receptor and the impact of 2,3,7,8-tetrachlorodibenzo-p-dioxin on cellular respiration and the mitochondrial proteome. Toxicol. Appl. Pharmacol. 2016;304:121\u2013132. doi: 10.1016/j.taap.2016.04.005.", "ArticleIdList": ["10.1016/j.taap.2016.04.005", "PMC4930739", "27105554"]}, {"Citation": "Dwier M., Michalek R., Saloupis P., McDonnell D., Malek G. Oxidized Lipids Activate Aryl Hydrocarbon Receptor (AhR) and Differentially Regulate Metabolic Pathways in Retinal Pigment Epithelial Cells (RPE) Invest. Ophtalmol. Vis. Sci. 2011;52:3328."}, {"Citation": "Mao K., Chen S., Chen M., Ma Y., Wang Y., Huang B., He Z., Zeng Y., Hu Y., Sun S., et al. Nitric oxide suppresses NLRP3 inflammasome activation and protects against LPS-induced septic shock. Cell Res. 2013;23:201\u2013212. doi: 10.1038/cr.2013.6.", "ArticleIdList": ["10.1038/cr.2013.6", "PMC3567828", "23318584"]}, {"Citation": "Laskin D.L., Sunil V., Guo Y., E Heck D., Laskin J.D. Increased nitric oxide synthase in the lung after ozone inhalation is associated with activation of NF-kappa B. Environ. Health Perspect. 1998;106:1175\u20131178. doi: 10.1289/ehp.98106s51175.", "ArticleIdList": ["10.1289/ehp.98106s51175", "PMC1533360", "9788894"]}, {"Citation": "Hogg N., Kalyanaraman B. Nitric oxide and lipid peroxidation. Biochim. Biophys. Acta. 1999;1411:378\u2013384. doi: 10.1016/S0005-2728(99)00027-4.", "ArticleIdList": ["10.1016/S0005-2728(99)00027-4", "10320670"]}, {"Citation": "Anderson E.J., A Katunga L., Willis M.S. Mitochondria as a source and target of lipid peroxidation products in healthy and diseased heart. Clin. Exp. Pharmacol. Physiol. 2011;39:179\u2013193. doi: 10.1111/j.1440-1681.2011.05641.x.", "ArticleIdList": ["10.1111/j.1440-1681.2011.05641.x", "PMC3827773", "22066679"]}, {"Citation": "Ceban F., Ling S., Lui L.M., Lee Y., Gill H., Teopiz K.M., Rodrigues N.B., Subramaniapillai M., Di Vincenzo J.D., Cao B., et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav. Immun. 2021;101:93\u2013135. doi: 10.1016/j.bbi.2021.12.020.", "ArticleIdList": ["10.1016/j.bbi.2021.12.020", "PMC8715665", "34973396"]}, {"Citation": "Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626\u2013631. doi: 10.1038/s41591-021-01292-y.", "ArticleIdList": ["10.1038/s41591-021-01292-y", "PMC7611399", "33692530"]}, {"Citation": "Merad M., Blish C.A., Sallusto F., Iwasaki A. The immunology and immunopathology of COVID-19. Science. 2022;375:1122\u20131127. doi: 10.1126/science.abm8108.", "ArticleIdList": ["10.1126/science.abm8108", "35271343"]}, {"Citation": "Andrade B.S., Siqueira S., Soares W.D.A., Rangel F.D.S., Santos N., Freitas A.D.S., da Silveira P.R., Tiwari S., Alzahrani K., G\u00f3es-Neto A., et al. Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms. Viruses. 2021;13:700. doi: 10.3390/v13040700.", "ArticleIdList": ["10.3390/v13040700", "PMC8072585", "33919537"]}, {"Citation": "Evans R.A., Leavy O.C., Richardson M., Elneima O., McCauley H.J.C., Shikotra A., Singapuri A., Sereno M., Saunders R.M., Harris V.C., et al. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: A prospective observational study. Lancet Respir. Med. 2022;10:761\u2013775. doi: 10.1016/S2213-2600(22)00127-8.", "ArticleIdList": ["10.1016/S2213-2600(22)00127-8", "PMC9034855", "35472304"]}, {"Citation": "Weinstock L.B., Brook J.B., Walters A.S., Goris A., Afrin L.B., Molderings G.J. Mast cell activation symptoms are prevalent in Long-COVID. Int. J. Infect. Dis. 2021;112:217\u2013226. doi: 10.1016/j.ijid.2021.09.043.", "ArticleIdList": ["10.1016/j.ijid.2021.09.043", "PMC8459548", "34563706"]}, {"Citation": "Kappelmann N., Dantzer R., Khandaker G.M. Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19. Psychoneuroendocrinology. 2021;131:105295. doi: 10.1016/j.psyneuen.2021.105295.", "ArticleIdList": ["10.1016/j.psyneuen.2021.105295", "PMC8172271", "34119855"]}, {"Citation": "Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., Juno J.A., Burrell L.M., Kent S.J., Dore G.J., et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 2022;23:210\u2013216. doi: 10.1038/s41590-021-01113-x.", "ArticleIdList": ["10.1038/s41590-021-01113-x", "35027728"]}, {"Citation": "Doykov I., H\u00e4llqvist J., Gilmour K.C., Grandjean L., Mills K., Heywood W.E. \u2018The long tail of Covid-19\u2019-The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Research. 2021;9:1349. doi: 10.12688/f1000research.27287.2.", "ArticleIdList": ["10.12688/f1000research.27287.2", "PMC7745182", "33391730"]}, {"Citation": "Chang J.D.S., Lu H.-S., Chang Y.-F., Wang D. Ameliorative effect of ozone on cytokine production in mice injected with human rheumatoid arthritis synovial fibroblast cells. Rheumatol. Int. 2004;26:142\u2013151. doi: 10.1007/s00296-004-0526-1.", "ArticleIdList": ["10.1007/s00296-004-0526-1", "15570426"]}, {"Citation": "Mart\u00ednez-S\u00e1nchez G., Schwartz A., Di Donna V. Potential Cytoprotective Activity of Ozone Therapy in SARS-CoV-2/COVID-19. Antioxidants. 2020;9:389. doi: 10.3390/antiox9050389.", "ArticleIdList": ["10.3390/antiox9050389", "PMC7278582", "32384798"]}, {"Citation": "Varesi A., Chirumbolo S., Ricevuti G. Oxygen\u2013ozone treatment and COVID-19: Antioxidants targeting endothelia lead the scenery. Intern. Emerg. Med. 2021;17:593\u2013596. doi: 10.1007/s11739-021-02865-y.", "ArticleIdList": ["10.1007/s11739-021-02865-y", "PMC8531908", "34677789"]}, {"Citation": "Wei A., Feng H., Jia X.-M., Tang H., Liao Y.-Y., Li B.-R. Ozone therapy ameliorates inflammation and endometrial injury in rats with pelvic inflammatory disease. Biomed. Pharmacother. 2018;107:1418\u20131425. doi: 10.1016/j.biopha.2018.07.137.", "ArticleIdList": ["10.1016/j.biopha.2018.07.137", "30257358"]}, {"Citation": "Tahmasebi S., Qasim M.T., Krivenkova M.V., Zekiy A.O., Thangavelu L., Aravindhan S., Izadi M., Jadidi-Niaragh F., Ghaebi M., Aslani S., et al. The effects of oxygen\u2013ozone therapy on regulatory T-cell responses in multiple sclerosis patients. Cell Biol. Int. 2021;45:1498\u20131509. doi: 10.1002/cbin.11589.", "ArticleIdList": ["10.1002/cbin.11589", "33724614"]}, {"Citation": "D\u00edaz-Resendiz K.J.G., Benitez-Trinidad A.B., Covantes-Rosales C.E., Toledo-Ibarra G.A., Ortiz-Lazareno P.C., Gir\u00f3n-P\u00e9rez D.A., Bueno-Dur\u00e1n A.Y., P\u00e9rez-D\u00edaz D.A., Barcelos-Garc\u00eda R.G., Gir\u00f3n-P\u00e9rez M.I. Loss of mitochondrial membrane potential (\u0394 \u03a8\u00a0m ) in leucocytes as post-COVID-19 sequelae. J. Leukoc. Biol. 2022;112:23\u201329. doi: 10.1002/JLB.3MA0322-279RRR.", "ArticleIdList": ["10.1002/JLB.3MA0322-279RRR", "PMC9088601", "35355308"]}, {"Citation": "Galam L., Failla A., Soundararajan R., Lockey R.F., Kolliputi N. 4-Hydroxynonenal regulates mitochondrial function in human small airway epithelial cells. Oncotarget. 2015;6:41508\u201341521. doi: 10.18632/oncotarget.6131.", "ArticleIdList": ["10.18632/oncotarget.6131", "PMC4747170", "26484418"]}, {"Citation": "Rai P., Janardhan K.S., Meacham J., Madenspacher J.H., Lin W.-C., Karmaus P.W.F., Martinez J., Li Q.-Z., Yan M., Zeng J., et al. IRGM1 links mitochondrial quality control to autoimmunity. Nat. Immunol. 2021;22:312\u2013321. doi: 10.1038/s41590-020-00859-0.", "ArticleIdList": ["10.1038/s41590-020-00859-0", "PMC7906953", "33510463"]}, {"Citation": "Paul B.D., Lemle M.D., Komaroff A.L., Snyder S.H. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc. Natl. Acad. Sci. USA. 2021;118:e2024358118. doi: 10.1073/pnas.2024358118.", "ArticleIdList": ["10.1073/pnas.2024358118", "PMC8403932", "34400495"]}, {"Citation": "Vollbracht C., Kraft K. Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of High-Dose Intravenous Vitamin C. Front. Pharmacol. 2022;13:899198. doi: 10.3389/fphar.2022.899198.", "ArticleIdList": ["10.3389/fphar.2022.899198", "PMC9100929", "35571085"]}, {"Citation": "Brodin P., Casari G., Townsend L., O\u2019Farrelly C., Tancevski I., L\u00f6ffler-Ragg J., Mogensen T.H., Casanova J.L., Abel L., Aiuti A., et al. Studying severe long COVID to understand post-infectious disorders beyond COVID-19. Nat. Med. 2022;28:879\u2013882. doi: 10.1038/s41591-022-01766-7.", "ArticleIdList": ["10.1038/s41591-022-01766-7", "35383311"]}, {"Citation": "Clavo B., Rodr\u00edguez-Esparrag\u00f3n F., Rodr\u00edguez-Abreu D., Mart\u00ednez-S\u00e1nchez G., Llontop P., Aguiar-Bujanda D., Fern\u00e1ndez-P\u00e9rez L., Santana-Rodr\u00edguez N. Modulation of Oxidative Stress by Ozone Therapy in the Prevention and Treatment of Chemotherapy-Induced Toxicity: Review and Prospects. Antioxidants. 2019;8:588. doi: 10.3390/antiox8120588.", "ArticleIdList": ["10.3390/antiox8120588", "PMC6943601", "31779159"]}, {"Citation": "Gali\u00e8 M., Costanzo M., Nodari A., Boschi F., Calderan L., Mannucci S., Covi V., Tabaracci G., Malatesta M. Mild ozonisation activates antioxidant cell response by the Keap1/Nrf2 dependent pathway. Free. Radic. Biol. Med. 2018;124:114\u2013121. doi: 10.1016/j.freeradbiomed.2018.05.093.", "ArticleIdList": ["10.1016/j.freeradbiomed.2018.05.093", "29864481"]}, {"Citation": "Mohamed M.S., Johansson A., Jonsson J., Schi\u00f6th H.B. Dissecting the Molecular Mechanisms Surrounding Post-COVID-19 Syndrome and Neurological Features. Int. J. Mol. Sci. 2022;23:4275. doi: 10.3390/ijms23084275.", "ArticleIdList": ["10.3390/ijms23084275", "PMC9028501", "35457093"]}, {"Citation": "Ercegovac M., Asanin M., Savic-Radojevic A., Ranin J., Matic M., Djukic T., Coric V., Jerotic D., Todorovic N., Milosevic I., et al. Antioxidant Genetic Profile Modifies Probability of Developing Neurological Sequelae in Long-COVID. Antioxidants. 2022;11:954. doi: 10.3390/antiox11050954.", "ArticleIdList": ["10.3390/antiox11050954", "PMC9138155", "35624818"]}, {"Citation": "Jarrott B., Head R., Pringle K.G., Lumbers E.R., Martin J.H. \u201cLONG COVID\u201d\u2014A hypothesis for understanding the biological basis and pharmacological treatment strategy. Pharmacol. Res. Perspect. 2022;10:e00911. doi: 10.1002/prp2.911.", "ArticleIdList": ["10.1002/prp2.911", "PMC8929332", "35029046"]}, {"Citation": "Crook H., Raza S., Nowell J., Young M., Edison P. Long covid\u2014mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.", "ArticleIdList": ["10.1136/bmj.n1648", "34312178"]}, {"Citation": "Di Girolamo F.G., Fiotti N., Sisto U.G., Nunnari A., Colla S., Mearelli F., Vinci P., Schincariol P., Biolo G. Skeletal Muscle in Hypoxia and Inflammation: Insights on the COVID-19 Pandemic. Front. Nutr. 2022;9:865402. doi: 10.3389/fnut.2022.865402.", "ArticleIdList": ["10.3389/fnut.2022.865402", "PMC9072827", "35529457"]}, {"Citation": "Karaarslan F., G\u00fcneri F.D., Karde\u015f S. Long COVID: Rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months. Clin. Rheumatol. 2021;41:289\u2013296. doi: 10.1007/s10067-021-05942-x.", "ArticleIdList": ["10.1007/s10067-021-05942-x", "PMC8553494", "34713356"]}, {"Citation": "Khan S.A., Seyam O., Smith N.L., Reid I., Gandhi J., Jiang W. Clinical utility of ozone therapy for musculoskeletal disorders. Med. Gas. Res. 2018;8:103\u2013110. doi: 10.4103/2045-9912.241075.", "ArticleIdList": ["10.4103/2045-9912.241075", "PMC6178642", "30319765"]}, {"Citation": "De Sire A., Agostini F., Lippi L., Mangone M., Marchese S., Cisari C., Bernetti A., Invernizzi M. Oxygen\u2013Ozone Therapy in the Rehabilitation Field: State of the Art on Mechanisms of Action, Safety and Effectiveness in Patients with Musculoskeletal Disorders. Biomolecules. 2021;11:356. doi: 10.3390/biom11030356.", "ArticleIdList": ["10.3390/biom11030356", "PMC7996934", "33652804"]}, {"Citation": "De Sire A., Marotta N., Ferrillo M., Agostini F., Sconza C., Lippi L., Respizzi S., Giudice A., Invernizzi M., Ammendolia A. Oxygen-Ozone Therapy for Reducing Pro-Inflammatory Cytokines Serum Levels in Musculoskeletal and Temporomandibular Disorders: A Comprehensive Review. Int. J. Mol. Sci. 2022;23:2528. doi: 10.3390/ijms23052528.", "ArticleIdList": ["10.3390/ijms23052528", "PMC8910188", "35269681"]}, {"Citation": "Akkawi I. Ozone therapy for musculoskeletal disorders Current concepts. Acta Biomed. 2020;91:e2020191. doi: 10.26717/BJSTR.2019.22.003737.", "ArticleIdList": ["10.26717/BJSTR.2019.22.003737", "PMC7927499", "33525293"]}, {"Citation": "Tirelli U., Franzini M., Valdenassi L., Pandolfi S., Berretta M., Ricevuti G., Chirumbolo S. Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Greatly Improved Fatigue Symptoms When Treated with Oxygen-Ozone Autohemotherapy. J. Clin. Med. 2021;11:29. doi: 10.3390/jcm11010029.", "ArticleIdList": ["10.3390/jcm11010029", "PMC8745272", "35011770"]}, {"Citation": "Tirelli U., Cirrito C., Pavanello M., Piasentin C., Lleshi A., Taibi R. Ozone therapy in 65 patients with fibromyalgia: An effective therapy. Eur. Rev. Med. Pharmacol. Sci. 2019;23:1786\u20131788. doi: 10.26355/eurrev_201902_17141.", "ArticleIdList": ["10.26355/eurrev_201902_17141", "30840304"]}, {"Citation": "Li Y., Feng X., Ren H., Huang H., Wang Y., Yu S. Low-Dose Ozone Therapy Improves Sleep Quality in Patients with Insomnia and Coronary Heart Disease by Elevating Serum BDNF and GABA. Bull. Exp. Biol. Med. 2021;170:493\u2013498. doi: 10.1007/s10517-021-05095-6.", "ArticleIdList": ["10.1007/s10517-021-05095-6", "33713235"]}, {"Citation": "Moghimi N., Di Napoli M., Biller J., Siegler J.E., Shekhar R., McCullough L.D., Harkins M.S., Hong E., Alaouieh D.A., Mansueto G., et al. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection. Curr. Neurol. Neurosci. Rep. 2021;21:44. doi: 10.1007/s11910-021-01130-1.", "ArticleIdList": ["10.1007/s11910-021-01130-1", "PMC8237541", "34181102"]}, {"Citation": "Mondelli V., Pariante C.M. What can neuroimmunology teach us about the symptoms of long-COVID? Oxf. Open Immunol. 2021;2:iqab004. doi: 10.1093/oxfimm/iqab004.", "ArticleIdList": ["10.1093/oxfimm/iqab004", "PMC7928677", "34192271"]}, {"Citation": "Scassellati C., Ciani M., Galoforo A.C., Zanardini R., Bonvicini C., Geroldi C. Molecular mechanisms in cognitive frailty: Potential therapeutic targets for oxygen-ozone treatment. Mech. Ageing Dev. 2020;186:111210. doi: 10.1016/j.mad.2020.111210.", "ArticleIdList": ["10.1016/j.mad.2020.111210", "31982474"]}, {"Citation": "Scassellati C., Galoforo A.C., Esposito C., Ciani M., Ricevuti G., Bonvicini C. Promising Intervention Approaches to Potentially Resolve Neuroinflammation And Steroid Hormones Alterations in Alzheimer\u2019s Disease and Its Neuropsychiatric Symptoms. Aging Dis. 2021;12:1337\u20131357. doi: 10.14336/AD.2021.0122.", "ArticleIdList": ["10.14336/AD.2021.0122", "PMC8279527", "34341712"]}, {"Citation": "Clavo B., Santana-Rodr\u00edguez N., Gutierrez D., Lopez J.C., Suarez G., Lopez L., Robaina F., Bocci V. Long-Term Improvement in Refractory Headache Following Ozone Therapy. J. Altern. Complement. Med. 2013;19:453\u2013458. doi: 10.1089/acm.2012.0273.", "ArticleIdList": ["10.1089/acm.2012.0273", "23215625"]}, {"Citation": "Haggiag S., Prosperini L., Stasolla A., Gerace C., Tortorella C., Gasperini C. Ozone-induced encephalopathy: A novel iatrogenic entity. Eur. J. Neurol. 2021;28:2471\u20132478. doi: 10.1111/ene.14793.", "ArticleIdList": ["10.1111/ene.14793", "33657263"]}, {"Citation": "Rangel K., Cabral F.O., Lechuga G.C., Carvalho J.P.R.S., Villas-B\u00f4as M.H.S., Midlej V., De-Simone S.G. Potent Activity of a High Concentration of Chemical Ozone against Antibiotic-Resistant Bacteria. Molecules. 2022;27:3998. doi: 10.3390/molecules27133998.", "ArticleIdList": ["10.3390/molecules27133998", "PMC9268618", "35807244"]}, {"Citation": "Roede J.R., Jones D.P. Reactive species and mitochondrial dysfunction: Mechanistic significance of 4-hydroxynonenal. Environ. Mol. Mutagen. 2010;51:380\u2013390. doi: 10.1002/em.20553.", "ArticleIdList": ["10.1002/em.20553", "PMC5906392", "20544880"]}, {"Citation": "Dodson M., Wani W.Y., Redmann M., Benavides G.A., Johnson M.S., Ouyang X., Cofield S.S., Mitra K., Darley-Usmar V., Zhang J. Regulation of autophagy, mitochondrial dynamics, and cellular bioenergetics by 4-hydroxynonenal in primary neurons. Autophagy. 2017;13:1828\u20131840. doi: 10.1080/15548627.2017.1356948.", "ArticleIdList": ["10.1080/15548627.2017.1356948", "PMC5788494", "28837411"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "3"}, {"Year": "2022", "Month": "9", "Day": "6"}, {"Year": "2022", "Month": "9", "Day": "7"}, {"Year": "2022", "Month": "9", "Day": "23", "Hour": "1", "Minute": "11"}, {"Year": "2022", "Month": "9", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "24", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "9", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["36140358", "PMC9496465", "10.3390/biomedicines10092258", "biomedicines10092258"]}}], "PubmedBookArticle": []}